A Gene Expression Signature of RAS Pathway Dependence Predicts Response to PI3K and RAS Pathway Inhibitors and Expands the Population of RAS Pathway Activated Tumors

BMC Medical Genomics - United Kingdom
doi 10.1186/1755-8794-3-26

Related search